NCT04602507 - Ivermectin in Adults With Severe COVID-19. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

December 9, 2021

Study Completion Date

December 9, 2021

Conditions

Covid19Severe Acute Respiratory Syndrome

Interventions

DRUG

Ivermectin

Routinary care offered in the hospital plus ivermectin 400 µg/kg (2 drops per kg) orally in a single dose.

OTHER

Placebo

Routinary care offered in the hospital plus placebo (2 drops per kg) orally in a single dose

Trial Locations (1)

Clinica CES, Medellín